State Street Corporation 13D and 13G filings for Vir Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-18 12:29 pm Sale | 2024-09-30 | 13G | Vir Biotechnology, Inc. VIR | STATE STREET CORP STT | 5,625,533 4.100% | -1,286,549 (-18.61%) | Filing |
| 2024-01-24 07:59 am Purchase | 2023-12-31 | 13G | Vir Biotechnology, Inc. VIR | STATE STREET CORP STT | 6,912,082 5.140% | 6,912,082 (New Position) | Filing |